Clemmer highlighted the Auryon laser atherectomy platform in peripheral arterial disease (PAD), which AngioDynamics entered after a 2019 acquisition and launched commercially in September 2020. He said the device uses laser energy to disrupt calcified plaque and open diseased arteries, and can also treat in-stent restenosis (ISR).He emphasized that AngioDynamics now reports in two operating segments, with MedTech positioned as the future growth engine and MedDevice described as a more mature business that g ...